Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Pneumococcal disease
Newborn
Risk group
Europe
Clear all
Type of publications
NITAG documentation
(6)
Systematic reviews (SYSVAC)
(1)
Topics
Available to download in languages
Regions
Europe
(7)
Africa
(1)
South-East Asia
(1)
Western Pacific
(4)
Countries
Belgium
(2)
France
(2)
Luxembourg
(1)
Ukraine
(1)
United Kingdom
(1)
Diseases
COVID-19
(4)
Pneumococcal disease
(3)
Hepatitis B
(1)
Herpes zoster
(1)
Influenza
(3)
Vaccine topics
Coverage
(1)
Target population
Newborn
(4)
Risk group
(3)
Adolescents
(5)
All age groups
(10)
Children
(8)
Healthcare workers
(6)
Older adults
(8)
Parents/caregivers
(4)
Pregnant women
(2)
Travellers
(1)
Publication date
2022
(3)
2021
(2)
2019
(1)
7 results found
2022
∙
Ludvigsson, J. F. Loboda, A.
Systematic review of health and disease in Ukrainian children highlights poor child health and challenges for those treating refugees
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against pneumococcal disease for adults in Belgium
2021
∙
JCVI
New COVID-19 vaccine advice for adults living with adults who are immunosuppressed
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2019
∙
Conseil Supérieur des Maladies Infectieuses
recommendations concerning the vaccination of children born prematurely
Haute Autorité de Santé
Vaccination strategy against pneumococcal infections - Place of the VAXNEUVANCE vaccine in children aged 6 weeks to 18 years
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register